Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
This intro covers Wash Sale Rule 61 Day Window Dividend ETF, detailing the 61-day period and its implications for replacements.
18,680 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
July 2026 brings a steadier backdrop for income seekers. Here are five safe monthly dividend stocks that provide regu...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...
As stocks edge higher in mid-2026, a 64-year dividend king stands out as a pristine entry point for income-focused in...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...
ExxonMobil stock surged January as energy markets moved higher, but the real story runs deeper than a single month. T...
As markets shift in early 2026, dividend-growth stocks offer retirees predictable income. Here are four blue chips wi...
When spacex just days away sparks market chatter, investors want to know what typically happens next. This guide brea...
Grow your portfolio with clarity. This guide compares Vanguard MEGA CAP Growth ETF (MGK) and iShares Russell 2000 ETF...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
Starting with $1,000 doesn't mean you have to settle for small gains. This guide lays out a clear framework to find t...